Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 134

Blog

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19

On Aug. 20, 2020, the La Jolla Institute for Immunology (LJI) announced that Erica Ollmann Saphire, Ph.D. had…

Read More La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19Continue

Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccine
COVID-19 | Life Science History | Vaccine

Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccine

On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…

Read More Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccineContinue

Evidence suggested children could play a larger role in community spread of COVID-19
COVID-19 | Life Science History

Evidence suggested children could play a larger role in community spread of COVID-19

On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…

Read More Evidence suggested children could play a larger role in community spread of COVID-19Continue

OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19
COVID-19 | Life Science History

OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19

On Aug. 20, 2020, OpGen announced that its subsidiary Curetis GmbH had obtained the CE mark certification in…

Read More OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19Continue

Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19
Life Science History | Vaccine

Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19

On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….

Read More Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19Continue

JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women
Life Science History

JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women

On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…

Read More JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected womenContinue

NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
COVID-19 | NIH

NIH imposed ‘outrageous’ conditions on resuming coronavirus grants

On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…

Read More NIH imposed ‘outrageous’ conditions on resuming coronavirus grantsContinue

CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populations
CDC | COVID-19 | Life Science History

CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populations

On Aug. 19, 2020, the CDC released a new study that specifically examines how COVID-19 is affecting American…

Read More CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populationsContinue

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2

On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…

Read More Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2Continue

Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing system
COVID-19 | FDA | Life Science History

Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing system

On Aug. 19, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…

Read More Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing systemContinue

Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
Biotechnology | COVID-19 | Life Science History

Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs

On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaᆴ SARS…

Read More Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabsContinue

BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
COVID-19 | Life Science History

BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions

On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…

Read More BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditionsContinue

Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeル COVID-19 probes and the BOND RX
COVID-19 | Life Science History

Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeル COVID-19 probes and the BOND RX

On Aug. 19, 2020, Bio-Techne in partnership with Leica Biosystems, announced the automation of RNAscopeル COVID-19 probes on…

Read More Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeル COVID-19 probes and the BOND RXContinue

Experimental COVID-19 vaccine prevented severe disease in mice
Biotechnology | COVID-19 | Vaccine

Experimental COVID-19 vaccine prevented severe disease in mice

On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…

Read More Experimental COVID-19 vaccine prevented severe disease in miceContinue

Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion
Life Science History

Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion

On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…

Read More Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billionContinue

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
Biotechnology | COVID-19 | Infectious Disease

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial

On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…

Read More UT Southwestern announced open enrollment for at-home COLCORONA clinical trialContinue

Spike protein of the new corona virus is more flexible than expected
Non-Profit Research | Vaccine

Spike protein of the new corona virus is more flexible than expected

On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…

Read More Spike protein of the new corona virus is more flexible than expectedContinue

HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
COVID-19 | Life Science History

HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response

On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…

Read More HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune responseContinue

Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
COVID-19 | Life Science History

Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19

On Aug. 18, 2020, Regeneron and Roche announced that they had joined forces in the fight against COVID-19…

Read More Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19Continue

NIH delivered $43 million to support convalescent plasma clinical trial
COVID-19 | Life Science History

NIH delivered $43 million to support convalescent plasma clinical trial

On Aug. 18, 2020, the National Institutes of Health awarded Albert Einstein College of Medicine and Montefiore a…

Read More NIH delivered $43 million to support convalescent plasma clinical trialContinue

Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
COVID-19 | Life Science History

Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia

On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…

Read More Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumoniaContinue

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
Biotechnology | COVID-19

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray

On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…

Read More Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal sprayContinue

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy
Biotechnology | Therapeutics

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy

On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…

Read More Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapyContinue

USDA confirmed SARS-CoV-2 in mink in Utah
COVID-19 | USDA | Veterinary

USDA confirmed SARS-CoV-2 in mink in Utah

On Aug. 17, 2020, the USDA National Veterinary Services Laboratories (NVSL) announced the first confirmed cases of SARS-CoV-2…

Read More USDA confirmed SARS-CoV-2 in mink in UtahContinue

FDA approved teatment for rare disease affecting optic nerves, spinal cord
Biotechnology | FDA | Neurology

FDA approved teatment for rare disease affecting optic nerves, spinal cord

On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…

Read More FDA approved teatment for rare disease affecting optic nerves, spinal cordContinue

PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detection
COVID-19 | Medical Device

PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detection

On Aug. 17, 2020, PerkinElmer announced the launch of a series of explorerル workstations for SARS-CoV-2 testing capable…

Read More PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detectionContinue

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa

On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…

Read More Novavax initiated efficacy trial of COVID-19 vaccine in South AfricaContinue

Sanofi acquired Principia Biopharma for $3.68 billion
Biotechnology | Pharmaceutical

Sanofi acquired Principia Biopharma for $3.68 billion

On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…

Read More Sanofi acquired Principia Biopharma for $3.68 billionContinue

XBiotech announced COVID-19 candidate therapy
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

XBiotech announced COVID-19 candidate therapy

On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…

Read More XBiotech announced COVID-19 candidate therapyContinue

FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
COVID-19 | FDA | Life Science History

FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing

On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…

Read More FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processingContinue

Page navigation

Previous PagePrevious 1 … 132 133 134 135 136 … 347 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search